Category

China

Daily Brief China: Meituan, Greatview Aseptic Packaging, China Education Group and more

By | China, Daily Briefs

In today’s briefing:

  • O2O Playing a More Prominent Role in China Street Drinks
  • Weekly Deals Digest (11 Aug) – GA Pack, Trend Micro, Descente, Fancl, Fuji Soft, C.I. TAKIRON
  • Technically Speaking, Breakouts and Breakdowns: HONG KONG (AUGUST 9)


O2O Playing a More Prominent Role in China Street Drinks

By Andy Fu

  • On August 7th, Meituan’s on-demand order volume reached a historical high of 98mn on surging orders from street drinks. Meituan has connected to the backend systems of street drink vendors;
  • Delivery order is a double-edged sword. It boosts volume at the expense of margin. Further, the ownership of the volume is questionable;
  • With Pin-hao-fan, Meituan already atomized the small restaurants. Now Meituan is playing the same trick with street drinks. The result will be more dramatic to the benefit of Meituan.

Weekly Deals Digest (11 Aug) – GA Pack, Trend Micro, Descente, Fancl, Fuji Soft, C.I. TAKIRON

By Arun George


Technically Speaking, Breakouts and Breakdowns: HONG KONG (AUGUST 9)

By David Mudd


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Swire Pacific (A), Yum China Holdings , Hang Seng Index, Semiconductor Manufacturing International Corp (SMIC), China Jinmao Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • Thoughts On Swire Properties (1972 HK)’s Buyback
  • Yum China (9987 HK): The Best Long-Term China Catering Play
  • EQD | The HSI Rebound Can Reach Higher Prices in August
  • SMIC (981.HK): Revenue and GM Continued to Trend Up in 3Q24
  • Morning Views Asia: China Jinmao Holdings


Thoughts On Swire Properties (1972 HK)’s Buyback

By David Blennerhassett


Yum China (9987 HK): The Best Long-Term China Catering Play

By Eric Chen

  • We believe Yum China remains the best long-term China catering play. 2Q24 results highlight the resiliency and agility of its business model and management to navigate tough environment.
  • While cost optimization drove bottom-line beat, we share management’s view that it is not one-off exercise but will strengthen the company’s operation efficiency moat and market leadership.
  • Macro concerns are well known and fully priced in in our view. Otherwise investors won’t have the opportunity to own the name for low double-digit P/E.

EQD | The HSI Rebound Can Reach Higher Prices in August

By Nico Rosti

  • In a previous insight we forecasted a rally for the Hang Seng Index in August. The picture has not changed, a positive close above 17344.60 is still possible.
  • Looking at our MRM SHORT WEEKLY model for the HSI we can see that it has not yet reached overbought levels, so it could rise further in the next weeks.
  • Conversely a SHORT trade will be possible from the levels we will indicate below.

SMIC (981.HK): Revenue and GM Continued to Trend Up in 3Q24

By Patrick Liao

  • Expected sequential revenue growth of 13% to 15%, gross margin expected between 18% and 20%.
  • The company has not increased capacity utilization through price cuts but supports customers in facing competition to maintain market share.
  • Inventory replenishment behavior will end in the third quarter, and fourth-quarter orders will more accurately reflect actual demand rather than the impact of restocking.

Morning Views Asia: China Jinmao Holdings

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: WeRide, China Vanke and more

By | China, Daily Briefs

In today’s briefing:

  • WeRide (WRD US) IPO: The Bull Case
  • Morning Views Asia: China Vanke , SK Hynix, Softbank Group, Tata Motors ADR, UPL Ltd, Wynn Macau Ltd


WeRide (WRD US) IPO: The Bull Case

By Arun George

  • WeRide (WRD US), a provider of autonomous driving products and services, seeks to raise between US$200 to US$300 million through a Nasdaq IPO.    
  • WeRide is the most commercially successful L4 autonomous driving company globally, measured by commercialization revenue in 2021, 2022 and 2023.
  • The bull case rests on a large TAM, strong product capabilities, near-term mass commercialization, articulation of a path to profitability, improving earnings quality and presence of blue-chip investors. 

Morning Views Asia: China Vanke , SK Hynix, Softbank Group, Tata Motors ADR, UPL Ltd, Wynn Macau Ltd

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Alibaba Group Holding , MGM China Holdings, Topsports International Holdings, China Resources Sanjiu Medical & Pharma, Yum China Holdings , Black Sesame Technologies, Kuaishou Technology, Cathay Pacific Airways, Hang Lung Properties, Li Auto and more

By | China, Daily Briefs

In today’s briefing:

  • Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?
  • BUY/SELL/HOLD: Hong Kong Stock Updates (August 6)
  • China: Passive Selling Expected Later This Month
  • CR Sanjiu (000999.CH) To Acquire Tasly Pharma (600535.CH) – SOEs Have High Enthusiasm for TCM Assets
  • Yum China (9987 HK): 2Q 2024 – Market Expansion Can’t Mask Macro Woes
  • Black Sesame IPO Trading – Lackluster Demand, Combined with Bad Timing
  • KS/Kuaishou (1024 HK): 2Q24 Preview, 2-Digit Growth, 5th Profitable Quarter, and Significant Upside
  • Cathay Pacific (293 HK, BUY, TP:9.90HKD): Decent Results, Stay the Course
  • Hang Lung Properties 101 HK: Dragged by China Slowing Luxury Retail, but Stock Too Cheap to Ignore
  • [Blue Lotus Transportation Sector Update]: Consolidation by BYD, LI and Huawei Continue


Alibaba (9988 HK/BABA) Dual Primary Listing: Are We There Yet?

By Brian Freitas

  • In its last update, Alibaba Group announced that the company was preparing for its primary listing in Hong Kong and the process was expected to complete by the end August.
  • The Board meets on 14 August to approve results for the three months ending June. Could there be an announcement on the dual primary listing too?
  • Mainland Chinese own between 3.5%-15.5% of companies that converted from Secondary to Dual-Primary in the last few years. Similar buying in Alibaba could take the stock higher from here. 

BUY/SELL/HOLD: Hong Kong Stock Updates (August 6)

By David Mudd


China: Passive Selling Expected Later This Month

By Brian Freitas

  • The China equity markets have continued to trade lower with the CSI 300 Index outperforming other mainland indices as the National Team continues to pump money into ETFs tracking the index.
  • We currently estimate selling of around US$1.39bn across 74 stocks listed on the mainland and in Hong Kong. There could be fewer deletions depending on the review date chosen.
  • The potential deletes have dropped a lot since the start of the calendar year with big underperformance versus the HSCEI Index, CSI 300 Index and CSI Smallcap 500 Index.

CR Sanjiu (000999.CH) To Acquire Tasly Pharma (600535.CH) – SOEs Have High Enthusiasm for TCM Assets

By Xinyao (Criss) Wang

  • China Resources Sanjiu plans to acquire 28% stake in Tasly for RMB6.21 billion at RMB14.85/share. The acquisition of Tasly is in line with the strategic direction of 14th Five-Year Plan.
  • China Resources is positioned as a leading enterprise in modern industrial chain of TCM by the SASAC.Due to policy support, TCM assets are more likely to be favored by SOEs.
  • The deal is positive for Tasly, whose valuation has room to rise further, but the market seems “skeptical” about China Resources Sanjiu’s decision, leading to a lackluster share price reaction. 

Yum China (9987 HK): 2Q 2024 – Market Expansion Can’t Mask Macro Woes

By Devi Subhakesan

  • Yum China Holdings (9987 HK) reported a marginal 1% year-on-year increase in 2Q2024 revenue, driven by new store additions despite a decline in same-store sales.
  • Despite a challenging business environment, it achieved 8% year-on-year profit growth in Q2 and stabilised margins through sharp cost management and operational efficiency initiatives.
  • Without a clear visibility in improvement in consumer sentiment and spending, expect the tough operating environment to limit Yum China’s revenue and profit growth potential.

Black Sesame IPO Trading – Lackluster Demand, Combined with Bad Timing

By Clarence Chu

  • Black Sesame Technologies (BLACKSES HK) raised around US$133m in its Hong Kong IPO, after pricing its IPO at the low-end.
  • Black Sesame International Holdings (BSIH) is an automotive-grade computing SoC and SoC-based intelligent vehicle solution provider.
  • We have covered various aspects of the deal in our previous note. In this note, we will talk about the demand and trading dynamics.

KS/Kuaishou (1024 HK): 2Q24 Preview, 2-Digit Growth, 5th Profitable Quarter, and Significant Upside

By Ming Lu

  • We believe revenue will grow by 11% YoY and the company will make money for the fifth consecutive quarter in 2Q24.
  • We believe both adverting and e-commerce revenue will grow strongly in 2Q24.
  • We set an upside of 140% and a price target at HK$104 for the end of 2025. Buy.

Cathay Pacific (293 HK, BUY, TP:9.90HKD): Decent Results, Stay the Course

By Mohshin Aziz

  • 1HFY24 net profit declined -15% YoY to HK$3.4 billion, in-line with consensus 
  • Interim dividend of HK$0.20/share, at 38% payout ratio. Typically, Cathay pays 50% payout ratio, and we can expect final dividend to be much larger
  • Maintain BUY with target price of HK$9.90 (+26% UPSIDE) implies 10x FY2024 PE, parity multiple against its arch-rival Singapore Airlines (SIA SP). 

Hang Lung Properties 101 HK: Dragged by China Slowing Luxury Retail, but Stock Too Cheap to Ignore

By Jacob Cheng

  • HLP malls, which focus on China luxury retail consumption, is facing headwind from slowing China economy and weaker consumption
  • The retail sales in its malls slowed down and recorded -13% yoy growth for 1H 2024.  Dividend cut was a negative surprise
  • However, market is forward looking and stock valuation is too cheap to ignore, we recommend long-term investors can look at this name

[Blue Lotus Transportation Sector Update]: Consolidation by BYD, LI and Huawei Continue

By Eric Wen

  • Market underestimates the size of China’s stimulus packages, which consist of Rmb150bn of EV trade-in’s by year end and Rmb3tn worth of industrial equipment upgrades over 5 years;
  • Consolidation by BYD, LI and Huawei in marketing share shall continue, profitably. Our TOP PICK is BYD.
  • Consolidation by BYD, LI and Huawei in marketing share shall continue, profitably. Our TOP PICK is BYD.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Greatview Aseptic Packaging, WeRide Corp, Horizon Robotics, New World Development, Eternal Beauty Holdings Limited, Hutchmed China Ltd, China Resources Beverage, Road King Infrastructure, Medco Energi and more

By | China, Daily Briefs

In today’s briefing:

  • GA Pack (468 HK): Stalemate Broken as Management Considers a Possible Counteroffer
  • GAPack (468 HK)’s Co-Founders (Almost) Walk The Walk
  • WeRide Pre-IPO – Peer Comparison – Boasting Partnerships, but Peers Aren’t Too Far Behind
  • Horizon Robotics IPO: High Valuation Is At Risk As NEV Production Forecasts Have Weakened
  • NWD 17 HK Update: De-Leveraging in Process, the Biggest Beneficiary of Fed Rate Cut Cycle
  • Eternal Beauty Pre-IPO Tearsheet
  • Hutchmed China Ltd (13.HK/​​HCM.US) 24H1 – Fruquintinib’s US Sales Beat; Break-Even Is Within Reach
  • China Resources Beverage Pre-IPO – Peer Comparison – Middling
  • Road King – ESG Report – Lucror Analytics
  • Morning Views Asia: Greentown China, Medco Energi, Vedanta Resources


GA Pack (468 HK): Stalemate Broken as Management Considers a Possible Counteroffer

By Arun George

  • Greatview Aseptic Packaging (468 HK) disclosed that Mr Bi Hua Jeff (CEO) and Mr Hong Gang (co-founder) are contemplating a possible voluntary conditional offer. The terms and conditions were not disclosed.
  • Due to the recent AGM protest votes, management needed to provide a credible alternative to shareholders to ensure that Shandong Xinjufeng Technology Packaging (301296 CH)’s offer failed.   
  • Shandong Xinjufeng’s likely game plan is to wait for a binding counteroffer, focus on satisfying the preconditions, and requisition an EGM again to get Board representation.

GAPack (468 HK)’s Co-Founders (Almost) Walk The Walk

By David Blennerhassett

  • To say Greatview Aseptic Packaging (468 HK)‘s management and Shandong Xinjufeng (301296 CH) (XJF) don’t get along is an understatement. GAPack has labelled XJF’s pre-conditional Offer hostile and unwelcome.
  • Last night (6th August), co-founders Jeff Bi and Gang Hong tabled a non-binding Offer. No price was mentioned. Collectively they hold 14.72% of shares out compared to XJF’s 26.8%.
  • A firm Offer (and price) would have been welcome, and this probably reflects on-going funding negotiations. But the announcement will give minorities pause if/when tendering into XJF’s Offer.

WeRide Pre-IPO – Peer Comparison – Boasting Partnerships, but Peers Aren’t Too Far Behind

By Clarence Chu

  • WeRide Corp (WER CH) is looking to raise around US$300m in its upcoming US IPO.
  • WeRide provides autonomous driving products and services from L2 to L4 of driving automation.
  • We had looked at the firm’s past performance in an earlier note. In this note, we will undertake a peer comparison.

Horizon Robotics IPO: High Valuation Is At Risk As NEV Production Forecasts Have Weakened

By Andrei Zakharov

  • Horizon Robotics, a leading provider of ADAS and AD solutions for passenger vehicles, plans to raise up to $500M in Hong Kong IPO.
  • I expect Horizon Robotics will price its IPO below last round valuation of ~$8.7B as revenue growth will slow below 50% y/y in 2024, down from 71% y/y in 2023.
  • The company’s key competitors, including Mobileye and Microchip Technology, revised their revenue guidance downwards for the second half of 2024.

NWD 17 HK Update: De-Leveraging in Process, the Biggest Beneficiary of Fed Rate Cut Cycle

By Jacob Cheng

  • In this update, we analyzed recent NWD’s corporate actions, which show their de-leveraging plan is on track
  • NWD, having the highest gearing among HK RE names, will become the biggest beneficiary if Fed starts a new rate cut cycle
  • Valuation is compelling.  There is ample upside assuming a bear case scenario.  It is a BUY

Eternal Beauty Pre-IPO Tearsheet

By Akshat Shah

  • Eternal Beauty Holdings Limited (EBHL12 HK) is looking to raise about US$200m in its upcoming Hong Kong IPO. The deal will be run by BNP Paribas, Citic, CMBI and DBS.
  • Eternal Beauty is the largest brand management company of perfumes in the combined markets of Mainland China, Hong Kong and Macau, in terms of retail sales in 2023.
  • The company has a diverse portfolio of iconic brands of not only perfumes, but also color cosmetics, skincare products, personal care products, eyewear and home fragrances under management.

Hutchmed China Ltd (13.HK/​​HCM.US) 24H1 – Fruquintinib’s US Sales Beat; Break-Even Is Within Reach

By Xinyao (Criss) Wang

  • Fruquintinib US sales continue to be the main performance driver. License-out expectations for surufatinib is low.Highlight for savolitinib is the combination with osimertinib for NSCLC, which would bring high growth.
  • Future playbook of HUTCHMED is “continued sharp reduction of expenses + milestones from Takeda based on fruquintinib overseas sales = rapid narrowng of losses”.2024 overseas market sales may exceed US$300m.
  • There is not much problem with HUTCHMED completing its performance guidance for the year 2024. Reasonable market value range for HUTCHMED is US$1.75-3.75 billion. Breakeven is expected in 2025.

China Resources Beverage Pre-IPO – Peer Comparison – Middling

By Sumeet Singh

  • China Resources Beverage is looking to raise US$1bn in its upcoming Hong Kong IPO.
  • China Resources Beverage manufactures and sells packaged drinking water and RTD soft beverages in China.
  • In our earlier note, we talked about the company’s past performance. In this note, we will undertake a peer comparison.

Road King – ESG Report – Lucror Analytics

By Leonard Law, CFA

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We assess Road King’s ESG as “Adequate”, in line with the Environmental, Social and Governance scores. Controversies are “Immaterial” and Disclosure is “Adequate”.


Morning Views Asia: Greentown China, Medco Energi, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: China Traditional Chinese Medicine, BYD, Prada S.P.A., Beijing Capital International Airport (BCIA), MDL Wholesale, New World Development, Saint Bella, China Oil And Gas and more

By | China, Daily Briefs

In today’s briefing:

  • China TCM (570.HK) Privatization Update – Things Are Still Manageable
  • China Consumption Weekly (5 Aug 2024): BYD, Tesla, Seres, Alibaba, New Oriental, TAL
  • The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (August 2)
  • BCIA (694 HK): Risk Reward Payoff Gets Increasingly Attractive
  • MDL Wholesale Pre-IPO Tearsheet
  • Morning Views Asia: Adani Ports & Special Economic Zone, Indika Energy, New World Development
  • Saint Bella IPO: Growth Story Intact, A First-Mover Advantage in Postpartum Care Market in China
  • China Oil & Gas – ESG Report – Lucror Analytics


China TCM (570.HK) Privatization Update – Things Are Still Manageable

By Xinyao (Criss) Wang

  • What disappoints investors is that privatization progress is slower-than-expected. Since approval is in “advanced stage”, August update is eye-catching. Investors may need more patience with this type of SOE deal. 
  • The key to the success of this privatization lies in whether CNPGC is willing to abide by its commitments. If yes, CNPGC will take all measures to solve the problems.
  • According to our valuation calculation, even without this privatization, HK$3.5/share is fair for China TCM. Reasonable share price is above HK$5/share. Don’t forget, the privatization is still on the agenda.

China Consumption Weekly (5 Aug 2024): BYD, Tesla, Seres, Alibaba, New Oriental, TAL

By Ming Lu

  • In July, BYD’s deliveries increased by 31% YoY and Tesla’s deliveries in mainland China increased by 47% YoY.
  • Alibaba Taobao will soften its “refund only” rule, but Alibaba Hellobike raised its usage price.
  • New Oriental revenue increased by 32% YoY and TAL revenue increased by 50% YoY in the May quarter.

The Heat Is On: News Flow and Sentiment in CHINA / HONG KONG (August 2)

By David Mudd


BCIA (694 HK): Risk Reward Payoff Gets Increasingly Attractive

By Eric Chen

  • Market’s muted response to the airport’s worse-than-expected 1H24 losses suggest investors are looking beyond.
  • While non-aviation businesses will remain under pressure in the near-term, potential for earnings growth from fare hike could be significant and is not at all reflected at current valuation.
  • Free cash flow turning positive in 2024 also open to door for restoring dividend payments, which will be another catalyst for stock re-rating. Risk reward payoff gets increasingly positive.   

MDL Wholesale Pre-IPO Tearsheet

By Ethan Aw

  • MDL Wholesale (WMHGCZ CH) is looking to raise about US$100m in its upcoming Hong Kong IPO. The deal will be run by UBS, CMS, CMBI, Deutsche Bank, BOCI, and China Galaxy.
  • MDL Wholesale is a leading food and FMCG distribution solution provider in China, providing a broad range of customers and retailers with high-quality merchandise and convenient solutions
  • Its solutions mainly include (i) food service and distribution, (ii) welfare and gifting, (iii) retailer distribution (comprising product sales to retailers and supply chain services) and (iv) merchandise wholesale. 

Morning Views Asia: Adani Ports & Special Economic Zone, Indika Energy, New World Development

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Saint Bella IPO: Growth Story Intact, A First-Mover Advantage in Postpartum Care Market in China

By Andrei Zakharov

  • Saint Bella, a premium postpartum care service provider, filed to go public in Hong Kong. UBS and CITIC Securities are leading the offering.
  • Saint Bella operates ultra-premium postpartum centers in Asia, which are located at luxury hotels and detached villas. The company opened its first postpartum center in Hangzhou in 2017.
  • With strong multi-brand strategy and asset-light business model, Saint Bella is uniquely positioned in premium segment under Saint Bella, Bella Isla and Baby Bella brands.

China Oil & Gas – ESG Report – Lucror Analytics

By Leonard Law, CFA

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We assess China Oil & Gas’ ESG as “Adequate”, in line with the Environmental, Social and Governance scores. Controversies are “Immaterial” and Disclosure is “Adequate”.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Chongqing Taiji Industry (Group) A, Shanghai Henlius Biotech , Black Sesame Technologies, CPMC Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • China Healthcare Weekly (Aug.4)- Taiji Group & China TCM, TCM Formula Granules VBP, Keymed’s Trouble
  • Merger Arb Mondays (05 Aug) – Henlius, Asia Cement, Canvest, GA Pack, CPMC, A8, Fancl
  • Black Sesame IPO – Paying Up-Front for Its Monetization Potential
  • CPMC Holdings (906.HK) Privatization Update- Due to Risk Behind ORG’s Offer, Baosteel Is a Wiser Bet


China Healthcare Weekly (Aug.4)- Taiji Group & China TCM, TCM Formula Granules VBP, Keymed’s Trouble

By Xinyao (Criss) Wang

  • TCM formula granules VBP would cause some disturbance to related enterprises’ performance, but the substitution of TCM formula granules for TCM decoction pieces is a trend, indicating long-term optimistic growth.
  • Keymed’s CM310 would probably miss the NRDL negotiation this year, which will put the Company in passive situation. Based on competitive landscape, we are worried about the performance of Keymed.
  • Unsatisfactory performance of Taiji’s shares is related to concerns on China TCM’s privatization/24H1 results.However, even without the integration with China TCM, Taiji’s market value should be more than RMB20 billion.


Black Sesame IPO – Paying Up-Front for Its Monetization Potential

By Clarence Chu

  • Black Sesame Technologies (BLACKSES HK) is looking to raise US$143m in its Hong Kong IPO.
  • Black Sesame International Holdings (BSIH) is an automotive-grade computing SoC and SoC-based intelligent vehicle solution provider.
  • In our earlier notes, we looked at the past performance of the deal. In this note, we discuss peers and share our thoughts on valuation.

CPMC Holdings (906.HK) Privatization Update- Due to Risk Behind ORG’s Offer, Baosteel Is a Wiser Bet

By Xinyao (Criss) Wang

  • Baosteel’s choice to maintain its original Offer may partly reflect its “confidence” in the deal. If investors bet that Huarui Offer will succeed, they need to bear some risks.
  • If investors choose to arbitrage at HK$7.21/share, annualized return is 9% assuming privatization would be completed in mid-Jan 2025.Such return may not be attractive considering the uncertainties behind the deal. 
  • If investors are optimistic about Baosteel’s final acquisition of CPMC, they can consider buying Baosteel shares, as Baosteel will become the new industry leader, with greater upside potential for valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Tencent, China Longyuan Power, Asia Cement China, China National Nuclear Power C and more

By | China, Daily Briefs

In today’s briefing:

  • HK Connect SOUTHBOUND Flows (To 2 Aug 2024); ETFs Get Sold; Tencent, SOEs, Utilities Bought
  • A/H Premium Tracker (To 2 Aug 2024): Policy Commentary Supports Consumers, AH Premia Drifting Wider
  • Asia Cement China (743 HK): Scheme Vote on 26 August Has a High Deal Break Risk
  • Asia Cement (743 HK): 26th August Vote. Shareholders Should Reject Terms
  • Mainland Connect NORTHBOUND Flows (To 2 Aug 2024): Small Net Positive Week But…


HK Connect SOUTHBOUND Flows (To 2 Aug 2024); ETFs Get Sold; Tencent, SOEs, Utilities Bought

By Travis Lundy

  • SOUTHBOUND was again a net buyer, for HK$9.2bn this week (now 26wks in a row of net buying), on smallish two-way volumes.
  • I’ve thought national team was buying banks for months. They were gone for a couple of weeks. Feels like they are back. 
  • There were three ETFs in the top five SOUTHBOUND sells this past week, reversing last week. Energy, Utilities, Telecoms bought. 

A/H Premium Tracker (To 2 Aug 2024): Policy Commentary Supports Consumers, AH Premia Drifting Wider

By Travis Lundy

  • The New/Better A-H Premium Tracker has tables, charts, measures galore to track A/H premium positioning, southbound and northbound positioning/volatility in pairs over time, etc.
  • SOUTHBOUND inflow strong. SOEs, Tencent, and Xiaomi leading. NORTHBOUND down four of five days this week, but net inflows on the week. Consumer discretionary bad.
  • Hs underperformed As again. 20d AH Premia performance is at the top of its multi-year range. I’d expect AH Premia to decline the next couple of weeks.

Asia Cement China (743 HK): Scheme Vote on 26 August Has a High Deal Break Risk

By Arun George

  • Asia Cement China (743 HK)’s IFA opines that Asia Cement (1102 TT)’s HK$3.22 privatisation offer is fair and reasonable. The scheme vote is on 26 August. 
  • The IFA valiantly justifies that an offer materially below net cash is fair and reasonable. The crux of the justification lies in the fortuitous disclosure of material capex requirements.
  • While no shareholder holds the 10% blocking stake, the high AGM minority participation rates, retail opposition and unconvincing IFA report suggest a high chance of a deal break.

Asia Cement (743 HK): 26th August Vote. Shareholders Should Reject Terms

By David Blennerhassett

  • Back on the 5th June, Chinese cement play Asia Cement China (743 HK) announced a rubbish HK$3.22/share Offer from its parent Asia Cement (1102 TT).
  • This best & final cash Offer was a ~ 45% premium to undisturbed, and a 37% discount to FY23’s net cash. It’s a 39% discount to 1H24’s net cash.
  • The Scheme Doc is now out, with a 26th August independent shareholder vote. And payment (if it were to occur) on 20th September. The IFA (unsurprisingly) says fair and reasonable. 

Mainland Connect NORTHBOUND Flows (To 2 Aug 2024): Small Net Positive Week But…

By Travis Lundy

  • The Quiddity Mainland Connect NORTHBOUND Monitor. Like the A/H Premium Monitor and HK Connect SOUTHBOUND Monitor. Lots of Flows/Position Tables and Charts with which to play.
  • Last week saw NORTHBOUND net BUY RMB 3.2bn of A-shares. Wednesday was a BIG buy day. Every other day was a net sell. 
  • HK and Mainland large caps generally performed equally, down but much better than the rest of the world, but Hs in H/A pairs underperformed.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: PCCW Ltd, AGBA Group Holding , Agile Property Holdings and more

By | China, Daily Briefs

In today’s briefing:

  • StubWorld: PCCW’s Premium To NAV Is Unsustainable
  • AGBA – Termination of coverage
  • Agile Group – ESG Report – Lucror Analytics


StubWorld: PCCW’s Premium To NAV Is Unsustainable

By David Blennerhassett

  • Continued stub losses are one thing. Ballooning PCCW Ltd (8 HK) parent debt is another. 
  • Preceding my comments on PCCW and HKT Ltd (6823 HK) are the current setup/unwind tables for Asia-Pacific Holdcos.
  • .These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

AGBA – Termination of coverage

By Edison Investment Research

Edison Investment Research is terminating coverage on AGBA (AGBA) and Norcros (NXR). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.


Agile Group – ESG Report – Lucror Analytics

By Leonard Law, CFA

Lucror Analytics’ ESG Scores are based on a 3-tiered scale and are adjusted for Controversies (if applicable).
We view Agile Group’s ESG as “Adequate”, in line with its Environmental and Social scores. That said, Governance is “Weak”. Controversies are “Immaterial” and Disclosure is “Adequate”.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: WeRide Corp, Budweiser Brewing APAC , DPC Dash, Luckin Coffee, China Shipbuilding Industry, International Housewares Retail and more

By | China, Daily Briefs

In today’s briefing:

  • WeRide Pre-IPO – The Positives – Large Monetisation Opportunity on the Horizon
  • Budweiser APAC (1876 HK): Weak 2Q2024. Premium Beer, Cheap Valuations
  • DPC Dash (1405.HK): 1H24 Profit Alert Validating Investment Case
  • WeRide Pre-IPO – The Negatives – Losses Have Widened, Still in the Early Stages of Commercialization
  • [Luckin Coffee (LKNCY US, SELL, TP US$16.5) TP Change]: Milkteaization Diminishes Differentiation
  • China’s Giant Invests $690 Million in Dry Docks as Tide Turns For Shipbuilding
  • International Housewares Retail (1373 HK): Inflection Point In Earnings, 8.8x PE, 9% Div Yield


WeRide Pre-IPO – The Positives – Large Monetisation Opportunity on the Horizon

By Clarence Chu

  • WeRide Corp (WER CH) is looking to raise around US$300m in its upcoming US IPO.
  • WeRide provides autonomous driving products and services from L2 to L4 of driving automation.
  • In this note, we will talk about the positive aspects of the deal.

Budweiser APAC (1876 HK): Weak 2Q2024. Premium Beer, Cheap Valuations

By Devi Subhakesan

  • Budweiser Brewing APAC (1876 HK)‘s  performance could improve from 2H2024, driven by a likely recovery in China’s premium beer market and favourable commodity prices.
  • Stock’s upside potential from current price levels seem to outweigh downside risk.
  • With a high dividend payout and strong free cash flow generation, Budweiser trades at a 5% dividend yield and an 11% FCF yield.

DPC Dash (1405.HK): 1H24 Profit Alert Validating Investment Case

By Eric Chen

  • Company issued 1H24 profit alert after market yesterday which significantly beat even the high-end sell-side expectations. 
  • Impressive SSSG and store-level unit economics imply sizable potential for operating leverage and earnings growth in the mid to long term.
  • The profit alert, along with 2Q operating data released earlier, reinforced our confidence in earnings estimates of RMB130 million/RMB300 million for FY24/25 respectively. 

WeRide Pre-IPO – The Negatives – Losses Have Widened, Still in the Early Stages of Commercialization

By Clarence Chu

  • WeRide Corp (WER CH) is looking to raise around US$300m in its upcoming US IPO.
  • WeRide provides autonomous driving products and services from L2 to L4 of driving automation.
  • In this note, we will talk about the not so positive aspects of the deal.

[Luckin Coffee (LKNCY US, SELL, TP US$16.5) TP Change]: Milkteaization Diminishes Differentiation

By Eric Wen

  • Luckin’s SSSG declined 20.9%YoY in the peak season, indicating diseconomies of scale for Luckin and a deteriorated competitive environment. We do not expect a quick turnaround in the near term.
  • We think Luckin has limited capability to further raise its prices in 3Q24, and expect its NPM to be 11.9%/7.1% in 3Q24/4Q24 as the new norm.
  • We keep SELL rating and lower TP to US$16.5/ADS. The stock trading at 20x/16x PE in 2024/2025, and we expect the NI to increase 15%CAGR in the next 2 years.

China’s Giant Invests $690 Million in Dry Docks as Tide Turns For Shipbuilding

By Caixin Global

  • China’s state-owned shipbuilding giant, China Shipbuilding Industry Co. Ltd. (601989.SH +2.12%), is to invest more than 5 billion yuan ($690 million) in two acquisition deals to expand its shipyard capacity and meet rising demand.
  • China Shipbuilding Industry, the Shanghai-listed arm of China State Shipbuilding Corp. Ltd. (CSSC), announced Saturday a 4.04 billion yuan acquisition of Tianjin Xingang Shipbuilding Heavy Industry Co. Ltd.’s assets in Lingang, northern China’s port city Tianjin.
  • The purchase includes a 500,000-ton and a 300,000 ton dry dock, each equipped with two gantry cranes, as well as associated plants, outfitting quays, ship repair docks, sea outlet docks and other shoreline facilities, according to the company’s filing.

International Housewares Retail (1373 HK): Inflection Point In Earnings, 8.8x PE, 9% Div Yield

By Sameer Taneja

  • FY24 marked a new low in earnings for International Housewares Retail (1373 HK), with core earnings falling 38% YoY to 101 mn HKD, placing it at 8.8x PE trailing.
  • Management continues to maintain an 80% payout, placing the stock at a ~9% dividend yield. It has more than 300 mn HKD of net cash (34% of Mkt cap).
  • The stock has been decimated and is down 63% from its peak in 2021. Earnings inflection looks around the corner. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars